alexa Strategist PLGA Nano-capsules To Deliver SiRNA For Inhibition Of Carcinoma And Neuroblastoma Cell Lines By Knockdown Of Proto-oncogene
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Nanotek & Expo
December 01-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Archana M Raichur, Toru Mizuki, Yutaka Nagaoka, Kazunori Kato, Toru Maekawa and D Sakthi Kumar
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439.S1.017
Unexpurgated and site targeted delivery of small interfering RNA (siRNA) that can silence the expression of disease related genes is still a great challenge in nano-gene delivery field. siRNA cellular/nuclear uptake, intracellular transport and endosomal release could critically contribute in improvement of delivery methods and development in RNAi therapeutics. Delivery approaches using non-viral agents like metal nanoparticles, magnetic nanoparticles, polymeric nano-particles, liposomes are widely used for gene knockdown in RNA interference. However the key challenge of complete delivery of siRNA, biodegradability of nanoparticles and their toxicity still exists and creates hindrance in gene delivery. Here it was used hollow; nearly mono-dispersed and FDA approved (polymer; poly D,L-lactide-co-glycolic. 50:50) PLGA nanoparticles as carriers for siRNA delivery. Cell penetrating peptides(CPPs) and custom designed peptide nucleic acids (PNAs) were conjugated using layer by layer technique on surface of nanoparticles with complete encapsulation of siRNA for site directed oncogene knockdown in cancer cells (neuroblastoma and carcinoma) resulting in apoptosis induced effect. The CPP-PNA-PLGA nano-capsulessiRNA nanoparticles were selectively uptaken into cells via endocytosis resulting in enhanced gene silencing compared to naked siRNA (72nMol siRNA was used). Silencing studies were conducted using RT-Real time PCR and apoptosis studies were carried on using flow cytometry.PLGA-HNPswere characterized using Scanning and Transmission Electron Microscopy, Dynamic Light Scattering and Zeta potential analysis. The cell proliferation and viability assays confirmed that there is 97% of reduction in cell dividing activity. Confocal analysis confirms the delivery and uptake of HNPs inside the nucleus of the cancer cells. It was found that the usage of PLGA HNPs using CPPs and PNAs could delivery almost 100% of siRNA safely inside the nucleus resulting in site targeted gene silencing in cancer cells.
Archana M Raichur is currently pursuing Doctoral course final year in Toyo University, Japan under Prof. D. Sakthikumar. She completed her Master?s in Philosophy with Distinction from University of Pune, India in Medical Sciences and currently working on Gene therapy Research using Nanotechnology.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version